Related Experiment Videos
Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84
F Mandelli1, M Tribalto, G Avvisati
1Department of Human Biopathology, University La Sapienza, Rome, Italy.
Cancer Treatment Reviews
|January 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cutaneous involvement in multiple myeloma. A rare entity.
Clinical case reports·2025
Clinicopathological definition, management and prognostic value of mogamulizumab-associated rash and other cutaneous events: A systematic review.
Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Maintenance phase in psoralen-ultraviolet A phototherapy of early-stage mycosis fungoides. A critically appraised topic.
The British journal of dermatology·2017
Unilesional folliculotropic mycosis fungoides: a true rarity in the clinico-pathologic spectrum?
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2015
Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.
Cancer treatment reviews·2026
Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.
Cancer treatment reviews·2026
Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.
Cancer treatment reviews·2026